Macrogenics (MGNX) Misses Q1 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
TD Cowen Downgrades MacroGenics (MGNX) to Hold
May 10, 2024 5:30 AM EDTTD Cowen analyst Boris Peaker downgraded MacroGenics (NASDAQ: MGNX) from Buy to Hold.
The analyst comments "Efficacy was promising with 44% and 37% cPSA50s and 18% and 25% cORRs at 2.0mg and 2.7mg, respectively. However, safety deteriorated from the abstract which raises material questions.... More
